Evidence map›Paper›PMID 37401383›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2023

Optimizing anesthesia and delivery approaches for dosing into lungs of mice.

Yurim Seo, Longhui Qiu, Mélia Magnen, Catharina Conrad, S Farshid Moussavi-Harami, Mark R Looney, Simon J Cleary

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yurim SeoDepartment of Medicine, University of California, San Francisco, California, United States.
Longhui QiuDepartment of Medicine, University of California, San Francisco, California, United States.
Mélia MagnenDepartment of Medicine, University of California, San Francisco, California, United States.
Catharina ConradDepartment of Medicine, University of California, San Francisco, California, United States.
S Farshid Moussavi-HaramiDepartment of Medicine, University of California, San Francisco, California, United States.
Mark R LooneyDepartment of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0003-0241-9190
Simon J ClearyDepartment of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0001-5573-6363
University of California, San Francisco · US

Funding

Immunobiology of the normal and injured lungR35HL161241 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARK ROBERTS LOONEY · 2022 to 2026
$4.2M
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular trapsR01AI160167 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOONEY, MARK ROBERTS · 2021 to 2025
$3.1M
Research Training in Pediatric Critical Care MedicineT32HD049303 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFREY R FINEMAN · 2006 to 2026
$3.1M
NHLBI NIH HHS R35 HL161241NIAID NIH HHS R01 AI160167NICHD NIH HHS T32 HD049303
6 · The paper itself

Abstract

Microbes, toxins, therapeutics, and cells are often instilled into lungs of mice to model diseases and test experimental interventions. Consistent pulmonary delivery is critical for experimental power and reproducibility, but we observed variation in outcomes between handlers using different anesthetic approaches for intranasal dosing in mice. We therefore used a radiotracer to quantify lung delivery after intranasal dosing under inhalational (isoflurane) versus injectable (ketamine/xylazine) anesthesia in C57BL/6 mice. We found that ketamine/xylazine anesthesia resulted in delivery of a greater proportion (52 ± 9%) of an intranasal dose to lungs relative to isoflurane anesthesia (30 ± 15%). This difference in pulmonary dose delivery altered key outcomes in models of viral and bacterial pneumonia, with mice anesthetized with ketamine/xylazine for intranasal infection with influenza A virus or

Indexed as

AnesthesiaAnestheticsIsofluraneKetamineAnimalsLungMiceMice, Inbred C57BLReproducibility of ResultsXylazineAnestheticsIsofluraneKetamineXylazinedosingintranasalintratracheallungmouse

Identifiers

PMID37401383
PMCPMC10625824
OpenAlexW4383058636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.